Axsome Therapeutics AXSM
NASDAQ AXSM
$148.40 +7.43 (+5.27%)
As of: Nov 11, 2026 · 11:45 AM EST

Axsome Therapeutics (AXSM) Return on Equity [ROE] (2016 - 2026)

Updated

Axsome Therapeutics (AXSM) recorded Return on Equity [ROE] of -166.73% in Q3 2026, up 145.92 percentage points from -312.65% a year earlier and up 111.29 percentage points from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2025, Axsome Therapeutics reported Return on Equity [ROE] of -252.11%, down 20.48 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of -182.58 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -231.63% in FY2024 (-72.42 pp), -159.21% in FY2023 (+139.76 pp), -298.97% in FY2022 (-97.45 pp) and -201.51% in FY2021 (-131.97 pp).
  • The Q3 2026 figure is the highest quarterly Return on Equity [ROE] since Q4 2023.
  • On a year-over-year basis, Return on Equity [ROE] has increased for five consecutive quarters, with an average year-over-year change of -10.75 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 908.52 percentage points in Q2 2023, against a drop of 868.90 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -278.02% (Q2 2026), -263.58% (Q1 2026) and -226.11% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Axsome Therapeutics 7.41 Bn 6.15 Bn 241.89 Mn -166.73%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -166.73%
Jun 30, 2026 -278.02%
Mar 31, 2026 -263.58%
Dec 31, 2025 -226.11%
Sep 30, 2025 -312.65%
Jun 30, 2025 -390.97%
Mar 31, 2025 -504.94%
Dec 31, 2024 -383.18%
Sep 30, 2024 -317.69%
Jun 30, 2024 -249.92%
Mar 31, 2024 -176.91%
Dec 31, 2023 -103.90%
Sep 30, 2023 -73.62%
Jun 30, 2023 -94.45%
Mar 31, 2023 -143.42%
Dec 31, 2022 -140.22%
Sep 30, 2022 -185.29%
Jun 30, 2022 -1,002.97%
Mar 31, 2022 -928.32%
Dec 31, 2021 -446.98%
API Access

Axsome Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AXSM&period=max&api_key=YOUR_API_KEY